Literature DB >> 18828199

Predictors of change in trunk muscle strength for patients with chronic low back pain randomized to lumbar fusion or cognitive intervention and exercises.

Anne Keller1, Jens Ivar Brox, Olav Reikerås.   

Abstract

OBJECTIVES: We have previously reported in two randomized controlled trials that cognitive intervention and exercises more effectively improved isokinetic trunk muscle strength than lumbar fusion and postoperative rehabilitation in patients with chronic low back pain. The aim of the present study was to predict changes in muscle strength as regard to changes in pain, function, fear-avoidance beliefs (self-rated questionnaires), changes in cross-sectional area and density of the back muscles and treatment.
METHODS: We assessed 1) isokinetic trunk muscle strength; 2) cross-sectional area and density of back muscles by computer-tomography (CT); and 3) pain, function, fear-avoidance beliefs, and self- efficacy for pain in the included patients at baseline and 1-year follow-up. Multiple regression analysis was performed with change in muscle strength as dependent variables, and changes in area/density and self-rated symptoms and treatment as independent variables.
RESULTS: The correlations between the change in muscle strength and change in both cross-sectional area and density were weak (r < 0.1) and nonsignificant and these variables were not included in the multiple regression analysis. The change in pain, change in fear-avoidance beliefs, change in self-efficacy for pain and treatment explained 46% of the change in muscle strength, with change in pain and treatment as significant predictors.
CONCLUSION: Our results emphasize the central role of pain and treatment for the improvements in muscle strength in patients with chronic low back pain.

Entities:  

Mesh:

Year:  2008        PMID: 18828199     DOI: 10.1111/j.1526-4637.2007.00333.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  7 in total

Review 1.  Is a positive clinical outcome after exercise therapy for chronic non-specific low back pain contingent upon a corresponding improvement in the targeted aspect(s) of performance? A systematic review.

Authors:  F Steiger; B Wirth; E D de Bruin; A F Mannion
Journal:  Eur Spine J       Date:  2011-11-10       Impact factor: 3.134

2.  The Development and Testing of a Checklist to Study Behaviour Change Techniques used in a Treatment Programme for Canadian Armed Forces Members with Chronic Non-specific Low Back Pain.

Authors:  Katherine Harman; Marsha MacRae; Michael Vallis
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

3.  Demand, Control and Support at Work Among Sick-Listed Patients with Neck or Back Pain: A Prospective Study.

Authors:  Kjersti Myhre; Bjørn Lau; Gunn Hege Marchand; Gunnar Leivseth; Erik Bautz-Holter; Cecilie Røe
Journal:  J Occup Rehabil       Date:  2016-06

4.  Cost-utility of cognitive behavioral therapy for low back pain from the commercial payer perspective.

Authors:  Giulia Norton; Christine M McDonough; Howard Cabral; Michael Shwartz; James F Burgess
Journal:  Spine (Phila Pa 1976)       Date:  2015-05-15       Impact factor: 3.468

5.  Translation and Validation of the Farsi Version of the Pain Management Self-Efficacy Questionnaire.

Authors:  Hayedeh Rezaei; Ali Faiek M Saeed; Kamel Abdi; Abbas Ebadi; Reza Ghanei Gheshlagh; Amanj Kurdi
Journal:  J Pain Res       Date:  2020-04-07       Impact factor: 3.133

6.  Characteristics of Back Muscle Strength in Patients with Scheduled for Lumbar Fusion Surgery due to Symptomatic Lumbar Degenerative Diseases.

Authors:  Won Hah Park; Chong Suh Lee; Kyung Chung Kang; Yong Gon Seo
Journal:  Asian Spine J       Date:  2014-10-18

7.  Assessment of isokinetic trunk muscle strength and its association with health-related quality of life in patients with degenerative spinal deformity.

Authors:  Sen Yang; Can Chen; Shiyu Du; Yong Tang; Kai Li; Xueke Yu; Jiulin Tan; Chengmin Zhang; Zhigang Rong; Jianzhong Xu; Wenjie Wu; Fei Luo
Journal:  BMC Musculoskelet Disord       Date:  2020-12-09       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.